Sbi Securities Co., Ltd. Vanda Pharmaceuticals Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 40 shares of VNDA stock, worth $213. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40
Previous 90
55.56%
Holding current value
$213
Previous $413,000
54.24%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VNDA
# of Institutions
150Shares Held
45.3MCall Options Held
20KPut Options Held
999K-
Black Rock Inc. New York, NY8.14MShares$43.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.57MShares$19 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.45MShares$18.4 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.12MShares$16.6 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.59MShares$13.8 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $301M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...